Clinical Drug Experience Knowledgebase

autologous hematopoietic cell (1 trial)

busulfan (myleran) (2 trials)

carboplatin (paraplatin) (2 trials)

cyclophosphamide (cytoxan) (4 trials)

cytarabine (cytosar-u) (1 trial)

dactinomycin (cosmegen) (3 trials)

doxorubicin (Doxil) (5 trials)

etoposide (vepesid) (5 trials)

ifosfamide (ifex) (2 trials)

melphalan (alkeran) (2 trials)

naltrexone (revia) (1 trial)

prednisone (meticorten) (1 trial)

sargramostim (leukine) (3 trials)

urea (1 trial)

vincristine (oncovin) (5 trials)

cisplatin (platinol) (1 trial)

epirubicin (ellence) (1 trial)

peripheral blood hematopoietic cell (2 trials)